State Street’s Oruka Therapeutics ORKA Stock Holding History

State Street’s Portfolio ORKA Stock Details ORKA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$254M	Buy	2,673,090 +1,059,629	+66%	+$70.6M	0.01%	903
2026 Q1	$79.1M	Buy	1,613,461 +229,614	+17%	+$7.98M	﹤0.01%	1504
2025 Q4	$41.9M	Buy	1,383,847 +731,819	+112%	+$20.4M	﹤0.01%	1837
2025 Q3	$12.5M	Buy	652,028 +279,222	+75%	+$4.14M	﹤0.01%	2504
2025 Q2	$4.18M	Buy	372,806 +286,125	+330%	+$2.98M	﹤0.01%	3023
2025 Q1	$889K	Buy	86,681 +61,658	+246%	+$769K	﹤0.01%	3458
2024 Q4	$485K	Buy	+25,023	New	+$610K	﹤0.01%	3624
2024 Q3	–	Sell	-4,976	Closed	-$229K	–	4349
2024 Q2	$229K	Hold	4,976	–	–	﹤0.01%	3780
2024 Q1	$106K	Sell	4,976 -952	-16%	-$18.9K	﹤0.01%	4024
2023 Q4	$121K	Hold	5,928	–	–	﹤0.01%	4019
2023 Q3	$143K	Sell	5,928 -42	-0.7%	-$1.03K	﹤0.01%	4022
2023 Q2	$145K	Hold	5,970	–	–	﹤0.01%	4107
2023 Q1	$143K	Hold	5,970	–	–	﹤0.01%	4187
2022 Q4	$169K	Hold	5,970	–	–	﹤0.01%	4172
2022 Q3	$148K	Hold	5,970	–	–	﹤0.01%	4271
2022 Q2	$178K	Buy	5,970 +142	+2%	+$4.01K	﹤0.01%	4265
2022 Q1	$161K	Hold	5,828	–	–	﹤0.01%	4462
2021 Q4	$150K	Hold	5,828	–	–	﹤0.01%	4459
2021 Q3	$207K	Buy	5,828 +75	+1%	+$2.77K	﹤0.01%	4346
2021 Q2	$241K	Buy	+5,753	New	+$240K	﹤0.01%	4144

Other funds holding ORKA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

State Street's ORKA Position: Q2 2026 in Review

State Street increased its Oruka Therapeutics (ORKA) stake by 66% in Q2 2026, buying an estimated $70.6M and bringing the position to 2,673,090 shares worth $254M. The position accounts for 0.01% of the portfolio, ranked #903.

State Street first reported a position in ORKA in Q2 2021 and has held it in 20 quarters since. 256 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

State Street held 2,673,090 shares of Oruka Therapeutics worth $254M as of Q2 2026.
State Street bought 1,059,629 Oruka Therapeutics shares in Q2 2026, an estimated $70.6M.
Oruka Therapeutics made up 0.01% of State Street's portfolio in Q2 2026, its #903 holding.
State Street first reported a position in Oruka Therapeutics in Q2 2021 and has held it in 20 quarters since.
256 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.